首页 > 最新文献

Journal of Legal Medicine最新文献

英文 中文
Screen for Lysosomal Storage Diseases, Save More Nevada Babies 筛查溶酶体贮积性疾病,拯救更多内华达州婴儿
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-05-21 DOI: 10.1080/01947648.2021.1914482
Kim Thu Nguyen, N. Nguyen, W. Havins
Screen for Lysosomal Storage Diseases, Save More Nevada Babies Kim Thu Nguyen, OMS-II, knguyen38@student.touro.edu, Nguyen Nguyen, OMS-II, nnguyen20@student.touro.edu Weldon Havins, MD, JD, LLM, FCLM, Professor Emeritus Touro University Nevada College of Osteopathic Medicine, Henderson, NV. Introduction In the US, the Recommended Uniform Screening Panel (RUSP) currently endorses 29 disorders for which newborns should be screened, given evidence of the benefits of early detection. With increasing knowledge of disease progression, new and improved treatment options, and development of efficient screening tests, the screening of newborns for lysosomal storage disorders (LSD) has been quickly gaining momentum in the last decade. In 2019, Nevada passed Senate Bill 291, mandating the screening of all conditions in the RUSP, including Pompe disease and mucopolysaccharidosis I (MPS I). Currently, improved screening technology can measure enzymatic activities for several LSDs in a single analysis, allowing for the conservation of labor, equipment, samples, and reagents. The aim of this study is to evaluate the feasibility and cost-effectiveness of adding Fabry and Gaucher disease to Nevada’s newborn screening panel once screening for Pompe disease and MPS I has been established. Methods We performed a systematic review of literature to identify evidence on the natural history of Fabry and GD, as well as availability and effectiveness of treatment options and screening tests. We also compiled a list of costs associated with common clinical manifestations of Fabry and GD that commonly occur prior to diagnosis without an early detection program. We then compared these costs to the estimated costs of screening. Results We have estimated that the cost of adding on the screening of these two LSDs, once screening for Pompe and MPS I is established, will cost approximately $89,205 per year. The estimated costs of management of Fabry and GD in the absence of early detection and treatment are shown below: 2021 American College of Legal Medicine JOURNAL OF LEGAL MEDICINE 2021, VOL. 41, NO. S1, 29–30 https://doi.org/10.1080/01947648.2021.1914482
筛查溶酶体淤积性疾病,拯救更多内华达州婴儿Kim Thu Nguyen, OMS-II, knguyen38@student.touro.edu, Nguyen Nguyen, OMS-II, nnguyen20@student.touro.edu Weldon Havins, MD, JD, LLM, FCLM,内华达州亨德森Touro大学内华达骨科医学院名誉教授。介绍在美国,推荐统一筛查小组(RUSP)目前认可29种疾病,新生儿应该进行筛查,因为早期发现的证据是有益的。随着对疾病进展的认识不断增加,新的和改进的治疗方案,以及有效筛查试验的发展,在过去十年中,对新生儿进行溶酶体贮积症(LSD)筛查的势头迅速增强。2019年,内华达州通过了参议院第291号法案,要求对RUSP中的所有条件进行筛选,包括庞贝病和粘多糖病I (MPS I)。目前,改进的筛选技术可以在一次分析中测量几种lsd的酶活性,从而节省了劳动力、设备、样品和试剂。本研究的目的是评估在Pompe病和MPS I筛查建立后,将Fabry和Gaucher病加入内华达州新生儿筛查组的可行性和成本效益。方法我们进行了系统的文献综述,以确定法布里和GD的自然史证据,以及治疗方案和筛选试验的可用性和有效性。我们还编制了一份与Fabry和GD常见临床表现相关的费用清单,这些临床表现通常发生在诊断之前,没有早期检测程序。然后,我们将这些成本与筛查的估计成本进行了比较。我们估计,一旦建立了Pompe和MPS I的筛查,增加这两种lsd的筛查成本每年约为89,205美元。在没有早期发现和治疗的情况下,法布里和GD管理的估计费用如下所示:2021年美国法律医学学院法律医学杂志2021年,第41卷,NO。S1, 29-30 https://doi.org/10.1080/01947648.2021.1914482
{"title":"Screen for Lysosomal Storage Diseases, Save More Nevada Babies","authors":"Kim Thu Nguyen, N. Nguyen, W. Havins","doi":"10.1080/01947648.2021.1914482","DOIUrl":"https://doi.org/10.1080/01947648.2021.1914482","url":null,"abstract":"Screen for Lysosomal Storage Diseases, Save More Nevada Babies Kim Thu Nguyen, OMS-II, knguyen38@student.touro.edu, Nguyen Nguyen, OMS-II, nnguyen20@student.touro.edu Weldon Havins, MD, JD, LLM, FCLM, Professor Emeritus Touro University Nevada College of Osteopathic Medicine, Henderson, NV. Introduction In the US, the Recommended Uniform Screening Panel (RUSP) currently endorses 29 disorders for which newborns should be screened, given evidence of the benefits of early detection. With increasing knowledge of disease progression, new and improved treatment options, and development of efficient screening tests, the screening of newborns for lysosomal storage disorders (LSD) has been quickly gaining momentum in the last decade. In 2019, Nevada passed Senate Bill 291, mandating the screening of all conditions in the RUSP, including Pompe disease and mucopolysaccharidosis I (MPS I). Currently, improved screening technology can measure enzymatic activities for several LSDs in a single analysis, allowing for the conservation of labor, equipment, samples, and reagents. The aim of this study is to evaluate the feasibility and cost-effectiveness of adding Fabry and Gaucher disease to Nevada’s newborn screening panel once screening for Pompe disease and MPS I has been established. Methods We performed a systematic review of literature to identify evidence on the natural history of Fabry and GD, as well as availability and effectiveness of treatment options and screening tests. We also compiled a list of costs associated with common clinical manifestations of Fabry and GD that commonly occur prior to diagnosis without an early detection program. We then compared these costs to the estimated costs of screening. Results We have estimated that the cost of adding on the screening of these two LSDs, once screening for Pompe and MPS I is established, will cost approximately $89,205 per year. The estimated costs of management of Fabry and GD in the absence of early detection and treatment are shown below: 2021 American College of Legal Medicine JOURNAL OF LEGAL MEDICINE 2021, VOL. 41, NO. S1, 29–30 https://doi.org/10.1080/01947648.2021.1914482","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"104 1","pages":"29 - 30"},"PeriodicalIF":0.4,"publicationDate":"2021-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80829756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Banning Condoms as Evidence against Sex Workers in Illegal Prostitution 禁止使用避孕套作为性工作者非法卖淫的证据
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-05-21 DOI: 10.1080/01947648.2021.1914480
Summer Mostafa, Anjali Renukunta, W. Havins
{"title":"Banning Condoms as Evidence against Sex Workers in Illegal Prostitution","authors":"Summer Mostafa, Anjali Renukunta, W. Havins","doi":"10.1080/01947648.2021.1914480","DOIUrl":"https://doi.org/10.1080/01947648.2021.1914480","url":null,"abstract":"","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"36 1","pages":"26 - 26"},"PeriodicalIF":0.4,"publicationDate":"2021-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81287440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The “Strawman” in the Process of Review and Evaluation of Complaints Regarding Controlled Substance Prescriptions 管制药品处方投诉审查与评价过程中的“稻草人”
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-05-21 DOI: 10.1080/01947648.2021.1914472
R. Briggs, D. Hilton, Joseph P. Hardy, W. Havins
{"title":"The “Strawman” in the Process of Review and Evaluation of Complaints Regarding Controlled Substance Prescriptions","authors":"R. Briggs, D. Hilton, Joseph P. Hardy, W. Havins","doi":"10.1080/01947648.2021.1914472","DOIUrl":"https://doi.org/10.1080/01947648.2021.1914472","url":null,"abstract":"","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"12 1","pages":"9 - 10"},"PeriodicalIF":0.4,"publicationDate":"2021-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82298326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of COVID-19 Isolation on Domestic Violence Calls in Southern Nevada COVID-19隔离对内华达州南部家庭暴力电话的影响
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-05-21 DOI: 10.1080/01947648.2021.1914474
Kenneth G. Denning, Omair Javaid, Joseph P. Hardy
COVID-19 has caused an unprecedented crisis globally In response, concern about the impact of stay-at-home orders on domestic violence have led to a consensus expecting a substantial increase in domestic violence The purpose of this study is to compare the amount of domestic violence calls made to southern Nevada police departments during April and May of the COVID-19 pandemic to the amount of calls received in the same months of the two previous years The data compares documented calls to three separate police departments--Las Vegas Metropolitan, North Las Vegas and Henderson--in Clark County in both April and May in 2018, 2019 and 2020 The calls collected in this study are based on specific call codes used by police departments to document calls relating to domestic violence, including domestic battery and family disturbance The results will be beneficial to better understanding the effects of crises on domestic violence and can inform policy regarding the response of law enforcement, healthcare professionals and others
新冠肺炎疫情在全球引发了前所未有的危机。对居家令对家庭暴力影响的担忧导致人们普遍认为家庭暴力会大幅增加。本研究的目的是比较2019冠状病毒疫情期间4月和5月内华达州南部警察局接到的家庭暴力电话数量与前两年同期接到的电话数量。在2018年4月和5月,2019年和2020年,在克拉克县的北拉斯维加斯和亨德森,本研究中收集的电话是基于警察部门使用的特定呼叫代码来记录与家庭暴力有关的电话,包括家庭暴力和家庭骚乱。研究结果将有助于更好地了解危机对家庭暴力的影响,并可以为执法、医疗专业人员和其他人的反应提供政策信息
{"title":"The Impact of COVID-19 Isolation on Domestic Violence Calls in Southern Nevada","authors":"Kenneth G. Denning, Omair Javaid, Joseph P. Hardy","doi":"10.1080/01947648.2021.1914474","DOIUrl":"https://doi.org/10.1080/01947648.2021.1914474","url":null,"abstract":"COVID-19 has caused an unprecedented crisis globally In response, concern about the impact of stay-at-home orders on domestic violence have led to a consensus expecting a substantial increase in domestic violence The purpose of this study is to compare the amount of domestic violence calls made to southern Nevada police departments during April and May of the COVID-19 pandemic to the amount of calls received in the same months of the two previous years The data compares documented calls to three separate police departments--Las Vegas Metropolitan, North Las Vegas and Henderson--in Clark County in both April and May in 2018, 2019 and 2020 The calls collected in this study are based on specific call codes used by police departments to document calls relating to domestic violence, including domestic battery and family disturbance The results will be beneficial to better understanding the effects of crises on domestic violence and can inform policy regarding the response of law enforcement, healthcare professionals and others","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"155 1","pages":"13 - 14"},"PeriodicalIF":0.4,"publicationDate":"2021-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77027928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enact a Safe Firearm Storage Law to Reduce Suicides and Unintentional Deaths in Nevada 制定一项安全枪支储存法,以减少内华达州的自杀和意外死亡
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-05-21 DOI: 10.1080/01947648.2021.1914468
Varchita Alishetti, Siri Magadi, W. Havins
{"title":"Enact a Safe Firearm Storage Law to Reduce Suicides and Unintentional Deaths in Nevada","authors":"Varchita Alishetti, Siri Magadi, W. Havins","doi":"10.1080/01947648.2021.1914468","DOIUrl":"https://doi.org/10.1080/01947648.2021.1914468","url":null,"abstract":"","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"11 1","pages":"1 - 2"},"PeriodicalIF":0.4,"publicationDate":"2021-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74529088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical and Legal Issues for Medical Professionals Using Social Media 医疗专业人员使用社交媒体的道德和法律问题
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-05-21 DOI: 10.1080/01947648.2021.1914471
M. Bressler, Alisa O. Girard, S. Felice, Deborah Kiehlmeier, William Blazey, J. Zampella
IntroductionSocial media (SM) is rapidly evolving as a dominant force in disseminating health information —and misinformation. Physicians engaging online are faced with new ethical and legal challe...
社交媒体(SM)正在迅速发展成为传播健康信息和错误信息的主导力量。从事在线工作的医生面临着新的道德和法律挑战。
{"title":"Ethical and Legal Issues for Medical Professionals Using Social Media","authors":"M. Bressler, Alisa O. Girard, S. Felice, Deborah Kiehlmeier, William Blazey, J. Zampella","doi":"10.1080/01947648.2021.1914471","DOIUrl":"https://doi.org/10.1080/01947648.2021.1914471","url":null,"abstract":"IntroductionSocial media (SM) is rapidly evolving as a dominant force in disseminating health information —and misinformation. Physicians engaging online are faced with new ethical and legal challe...","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"2 1","pages":"5 - 8"},"PeriodicalIF":0.4,"publicationDate":"2021-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83156949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Take Away from COVID-19 Outbreak: Enhancing Jails' and Prisons' Abilities in Response to a Future Pandemic. 远离新冠肺炎疫情:提高监狱和监狱应对未来疫情的能力。
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-01-01 DOI: 10.1080/01947648.2021.1935634
Shuyu Zhong
{"title":"Take Away from COVID-19 Outbreak: Enhancing Jails' and Prisons' Abilities in Response to a Future Pandemic.","authors":"Shuyu Zhong","doi":"10.1080/01947648.2021.1935634","DOIUrl":"https://doi.org/10.1080/01947648.2021.1935634","url":null,"abstract":"","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"41 1-2","pages":"109-119"},"PeriodicalIF":0.4,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/01947648.2021.1935634","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39211978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curbing a Stealth Health Threat: Regulation of Child-Directed "Stealth" Junk Food Marketing. 遏制隐形的健康威胁:针对儿童的“隐形”垃圾食品营销的监管。
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-01-01 DOI: 10.1080/01947648.2021.1935632
Ellen Smith Yost
{"title":"Curbing a Stealth Health Threat: Regulation of Child-Directed \"Stealth\" Junk Food Marketing.","authors":"Ellen Smith Yost","doi":"10.1080/01947648.2021.1935632","DOIUrl":"https://doi.org/10.1080/01947648.2021.1935632","url":null,"abstract":"","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"41 1-2","pages":"83-93"},"PeriodicalIF":0.4,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/01947648.2021.1935632","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39211975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dispelling Medico-Legal Misconceptions Impeding Use of Advance Instructions to Shorten Immersion in Deep Dementia. 消除妨碍使用预先指导缩短深度痴呆患者浸入时间的医疗法律误解。
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-01-01 DOI: 10.1080/01947648.2021.1919252
Norman L Cantor

Progressive dementia afflicts millions of people, ultimately entailing precipitous mental decline and years of complete dependence on others. Many people deem the prospect of serious cognitive dysfunction, helplessness, and dependence to be intolerably degrading (as well as overly burdensome on others). To avoid being mired in prolonged dementia, they prefer to hasten death by advance instructions rejecting life-sustaining medical intervention at a point of decline they define as unacceptable.Some health care providers resist implementation of such advance instructions, especially as applied to patients with dementia who are not ostensibly suffering in their demented states and no longer recall their prior instructions and the dignity concerns that underlay them. The clash between advance wishes to hasten death and some health care providers' preference to maintain the well-being of nonsuffering patients will be surfacing, in coming years, in institutional ethics committees, professional disciplinary forums, and the courts. This article defends the legal and moral status of advance instructions seeking to shorten the unwanted limbo of deep dementia.

进行性痴呆症折磨着数百万人,最终导致智力急剧下降,并且多年来完全依赖他人。许多人认为严重的认知功能障碍、无助和依赖的前景是难以忍受的退化(以及对他人的过度负担)。为了避免陷入长期痴呆的泥潭,他们宁愿提前接受指示,在他们认为不可接受的衰退点上拒绝维持生命的医疗干预,从而加速死亡。一些卫生保健提供者拒绝执行这种预先指示,特别是当这些指示适用于痴呆症患者时,这些患者表面上并没有处于痴呆状态,也不再记得他们先前的指示,也不记得它们背后的尊严问题。在未来的几年里,在机构伦理委员会、专业纪律论坛和法庭上,加速死亡的预先愿望与一些医疗服务提供者倾向于维护无痛苦病人的福祉之间的冲突将会浮出水面。这篇文章为寻求缩短深度痴呆的危险状态的预先指示的法律和道德地位进行了辩护。
{"title":"Dispelling Medico-Legal Misconceptions Impeding Use of Advance Instructions to Shorten Immersion in Deep Dementia.","authors":"Norman L Cantor","doi":"10.1080/01947648.2021.1919252","DOIUrl":"https://doi.org/10.1080/01947648.2021.1919252","url":null,"abstract":"<p><p>Progressive dementia afflicts millions of people, ultimately entailing precipitous mental decline and years of complete dependence on others. Many people deem the prospect of serious cognitive dysfunction, helplessness, and dependence to be intolerably degrading (as well as overly burdensome on others). To avoid being mired in prolonged dementia, they prefer to hasten death by advance instructions rejecting life-sustaining medical intervention at a point of decline they define as unacceptable.Some health care providers resist implementation of such advance instructions, especially as applied to patients with dementia who are not ostensibly suffering in their demented states and no longer recall their prior instructions and the dignity concerns that underlay them. The clash between advance wishes to hasten death and some health care providers' preference to maintain the well-being of nonsuffering patients will be surfacing, in coming years, in institutional ethics committees, professional disciplinary forums, and the courts. This article defends the legal and moral status of advance instructions seeking to shorten the unwanted limbo of deep dementia.</p>","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"41 1-2","pages":"29-46"},"PeriodicalIF":0.4,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/01947648.2021.1919252","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39211973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Other Three Waves: Re-assessing the Impact of Industry-Prescriber Relations on the Opioid Crisis. 其他三波:重新评估行业-处方关系对阿片类药物危机的影响。
IF 0.4 4区 医学 Q3 LAW Pub Date : 2021-01-01 DOI: 10.1080/01947648.2021.1929589
Jessica Bresler, Michael S Sinha

As the opioid crisis in the United States evolved, so did the relationship between prescribers and pharmaceutical companies that manufacture prescription opioids, with policymakers at both the state and national levels focused on the issue of prescription opioid misuse. This article discusses the role of the prescriber-pharmaceutical company relationship with respect to opioid over- and underprescribing, the evolution of that relationship over time, and its contribution to what is now commonly known as the U.S. opioid crisis or overdose epidemic. The United States saw several "waves" of prescription opioid misuse, and this article characterizes the relationship between prescribers and pharmaceutical companies in similar waves. The article proposes several prescriber- and manufacturer-focused "solutions" that can be implemented to address and lessen the effects of the ongoing crisis. Changes directed at prescribers and manufacturers must be implemented in tandem to ensure such solutions do not, in attempting to fill the existing cracks in the system, create even more.

随着美国阿片类药物危机的演变,处方者与生产处方阿片类药物的制药公司之间的关系也在演变,州和国家层面的政策制定者都关注处方阿片类药物滥用问题。本文讨论了处方-制药公司在阿片类药物过量和不足处方方面的作用,这种关系随着时间的推移而演变,以及它对现在俗称的美国阿片类药物危机或过量流行的贡献。美国经历了几次处方阿片类药物滥用的“浪潮”,本文描述了类似浪潮中处方者和制药公司之间的关系。这篇文章提出了几个以处方者和制造商为中心的“解决方案”,可以用来解决和减轻持续危机的影响。针对开处方者和制造商的改革必须同时实施,以确保这些解决方案不会试图填补系统中现有的裂缝,从而造成更多的裂缝。
{"title":"The Other Three Waves: Re-assessing the Impact of Industry-Prescriber Relations on the Opioid Crisis.","authors":"Jessica Bresler,&nbsp;Michael S Sinha","doi":"10.1080/01947648.2021.1929589","DOIUrl":"https://doi.org/10.1080/01947648.2021.1929589","url":null,"abstract":"<p><p>As the opioid crisis in the United States evolved, so did the relationship between prescribers and pharmaceutical companies that manufacture prescription opioids, with policymakers at both the state and national levels focused on the issue of prescription opioid misuse. This article discusses the role of the prescriber-pharmaceutical company relationship with respect to opioid over- and underprescribing, the evolution of that relationship over time, and its contribution to what is now commonly known as the U.S. opioid crisis or overdose epidemic. The United States saw several \"waves\" of prescription opioid misuse, and this article characterizes the relationship between prescribers and pharmaceutical companies in similar waves. The article proposes several prescriber- and manufacturer-focused \"solutions\" that can be implemented to address and lessen the effects of the ongoing crisis. Changes directed at prescribers <i>and</i> manufacturers must be implemented in tandem to ensure such solutions do not, in attempting to fill the existing cracks in the system, create even more.</p>","PeriodicalId":44014,"journal":{"name":"Journal of Legal Medicine","volume":"41 1-2","pages":"47-81"},"PeriodicalIF":0.4,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/01947648.2021.1929589","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39211972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Legal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1